Our Management Team

Mr John Bennetts


Having begun his career as a practicing solicitor, John Bennetts has gone on to become an experienced investor and has been the founder and director of several successful Australian companies. With businesses spanning across the technology, finance and manufacturing industries, John is a substantial shareholder and director of ASX listed McMillan Shakespeare, and founder of medical diagnostic company Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Ltd (M-Group).
Prior to the establishment of the M-Group, John was a senior executive of the pioneering Australian multinational IT company, Datacraft Limited. John is also a director of several charitable organisations.

Dr James Rothel


Jim Rothel is an executive with over 30 years of experience in biological research and development, particularly within the area of diagnostics. The recipient of a PhD from Melbourne University, Jim was a member of the CSIRO team that invented a novel, interferon-γ based, method for measuring cellular immune responses in vitro. The team developed a diagnostic test for bovine tuberculosis that was awarded the CSIRO Medal for Research Achievement. In the mid-1990s, Jim joined CSL to further develop the same technology into a test for human tuberculosis, called QuantiFERON-TB.

QuantiFERON was later acquired by Cellestis and became the worldwide gold standard for diagnosis of tuberculosis infection.

Jim was Cellestis CSO and Executive Director until its acquisition by QIAGEN NV in 2011. In recognition of his contributions, Jim was awarded the prestigious Clunies Ross Award for application of technology in 2013.

Mr Ezequiel Peña

General Manager

With over 10 years of experience in marketing and management spanning across various industries, Ezequiel joined the Glutagen team in 2016. Ezequiel was part of the team responsible for turning decades of innovative scientific research into GluteGuard, a product capable of improving the quality of life of people living with gluten sensitivities. In his role as General Manager, Ezequiel oversees day-to-day operations, including manufacturing and supply; research and development; as well as managing Glutagen’s marketing team.